These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
91 related articles for article (PubMed ID: 14747244)
1. Lowering the cut point for impaired fasting glucose: where is the evidence? Where is the logic? Schriger DL; Lorber B Diabetes Care; 2004 Feb; 27(2):592-601. PubMed ID: 14747244 [No Abstract] [Full Text] [Related]
2. [Impact of lowering the cut-point for impaired fasting glucose on the distribution of impaired glucose regulation subcategories in Chinese adult population]. Yang ZJ; Yang WY; Xiao JZ; Li GW; Wang Y Zhonghua Yi Xue Za Zhi; 2004 Nov; 84(21):1773-6. PubMed ID: 15631770 [TBL] [Abstract][Full Text] [Related]
3. Fasting plasma glucose is a useful test for the detection of gestational diabetes. Brazilian Study of Gestational Diabetes (EBDG) Working Group. Reichelt AJ; Spichler ER; Branchtein L; Nucci LB; Franco LJ; Schmidt MI Diabetes Care; 1998 Aug; 21(8):1246-9. PubMed ID: 9702428 [TBL] [Abstract][Full Text] [Related]
4. How to minimize missing those subjects with high 2HR plasma glucose but 'normal' fasting plasma glucose levels? Ko GT; Cockram CS; Chan JC J Med; 2001; 32(1-2):53-65. PubMed ID: 11321888 [TBL] [Abstract][Full Text] [Related]
5. Poor specificity of fasting plasma glucose cut-off values in ruling out glucose intolerance: the complementary usefulness of OGTT. Sainaghi PP; Castello L; Limoncini AM; Bergamasco L; Bartoli E; Schianca GP Exp Clin Endocrinol Diabetes; 2007 Feb; 115(2):112-7. PubMed ID: 17318771 [TBL] [Abstract][Full Text] [Related]
7. Fasting versus postload glucose levels: why the controversy? Gerstein HC Diabetes Care; 2001 Nov; 24(11):1855-7. PubMed ID: 11679446 [No Abstract] [Full Text] [Related]
8. Making things easier is not so easy. The 1997 American Diabetes Association criteria and glucose intolerance. Aguilar-Salinas CA; García-García E; Lerman-Garber I; Gómez-Pérez FJ; Rull JA Diabetes Care; 1998 Jun; 21(6):1027-8. PubMed ID: 9614628 [No Abstract] [Full Text] [Related]
9. Fasting blood glucose and diagnosis of type 2 diabetes. Islam MS Diabetes Res Clin Pract; 2011 Jan; 91(1):e26. PubMed ID: 21030102 [No Abstract] [Full Text] [Related]
10. Lowering the criterion for impaired fasting glucose: impact on disease prevalence and associated risk of diabetes and ischemic heart disease. Tai ES; Goh SY; Lee JJ; Wong MS; Heng D; Hughes K; Chew SK; Cutter J; Chew W; Gu K; Chia KS; Tan CE Diabetes Care; 2004 Jul; 27(7):1728-34. PubMed ID: 15220254 [TBL] [Abstract][Full Text] [Related]
11. Screening and diagnosis of prediabetes: where are we headed? Alberti KG Diabetes Obes Metab; 2007 Sep; 9 Suppl 1():12-6. PubMed ID: 17877542 [TBL] [Abstract][Full Text] [Related]
12. Serum uric acid levels improve prediction of incident type 2 diabetes in individuals with impaired fasting glucose: the Rancho Bernardo study: response to Kramer et al. Oda E; Kawai R Diabetes Care; 2009 Oct; 32(10):e125; author reply e126. PubMed ID: 19793999 [No Abstract] [Full Text] [Related]
13. Detecting diabetes and impaired glucose tolerance in patients with atherosclerotic peripheral arterial disease. Green FC; Levison R; Newton DJ; Littleford R; Stonebridge PA; Belch JJ Int Angiol; 2012 Apr; 31(2):125-8. PubMed ID: 22466976 [TBL] [Abstract][Full Text] [Related]
15. New insights from continuous glucose monitoring into the route to diabetes. Colas A; Vigil L; Rodríguez de Castro C; Vargas B; Varela M Diabetes Metab Res Rev; 2018 Jul; 34(5):e3002. PubMed ID: 29516622 [TBL] [Abstract][Full Text] [Related]
16. All pre-diabetes is not the same: metabolic and vascular risks of impaired fasting glucose at 100 versus 110 mg/dl: the Screening for Impaired Glucose Tolerance study 1 (SIGT 1). Phillips LS; Weintraub WS; Ziemer DC; Kolm P; Foster JK; Vaccarino V; Rhee MK; Budhwani RK; Caudle JM Diabetes Care; 2006 Jun; 29(6):1405-7. PubMed ID: 16732034 [No Abstract] [Full Text] [Related]
17. Fasting plasma glucose versus glucose challenge test: screening for gestational diabetes and cost effectiveness. Rey E; Hudon L; Michon N; Boucher P; Ethier J; Saint-Louis P Clin Biochem; 2004 Sep; 37(9):780-4. PubMed ID: 15329316 [TBL] [Abstract][Full Text] [Related]
18. The prevalence of glucose intolerance in Japanese schizophrenic patients with a normal fasting glucose level. Ono S; Suzuki Y; Fukui N; Sugai T; Watanabe J; Tsuneyama N; Saito M; Someya T J Clin Psychopharmacol; 2013 Aug; 33(4):525-7. PubMed ID: 23775046 [TBL] [Abstract][Full Text] [Related]
19. Post-absorptive glucose lowering in normal healthy individuals: an epidemiological observation. Vasan SK; Ramachandran P; Mathew M; Natraj CV; Antonisamy B; Thomas N Diabetes Res Clin Pract; 2014 Apr; 104(1):e5-7. PubMed ID: 24565212 [TBL] [Abstract][Full Text] [Related]
20. [Borderline type, impaired glucose tolerance (IGT), and impaired fasting glucose (IFG): their concepts, classification and significance]. Kuzuya T Nihon Rinsho; 2005 Feb; 63 Suppl 2():15-20. PubMed ID: 15779339 [No Abstract] [Full Text] [Related] [Next] [New Search]